සැකිල්ල:Infobox drug/testcases6

1/mab
	some images
Monoclonal antibody
Type	F(ab')2 fragment
Source	Chimeric (rat/human)
Target	13
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN; US DailyMed: 32; US FDA: 31;
Pregnancy; category	AU: B3; 35;
Dependence; liability	43-1
Addiction; liability	43-2
Routes of; administration	44
ATC code	5455 (WHO) 56;
Legal status
Legal status	AU: S4 (Prescription only) S4-cmt; CA: Schedule IV; UK: POM (Prescription only); US: Schedule III; UN: Narcotic Schedules II and III; EU: Category 2 Precursor; In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
CAS Number	5051 52;
PubChem CID	57;
PubChem SID	58;
IUPHAR/BPS	59;
DrugBank	60101;
ChemSpider	6162;
UNII	63;
KEGG	6566;
ChEBI	CHEBI:6768;
ChEMBL	ChEMBL6970;
NIAID ChemDB	71;
PDB ligand	73 (PDBe, RCSB PDB);
Chemical and physical data
Formula	CH2Ag3Al4As5Au6B7Bi8−1
Molar mass	75
3D model (JSmol)	Interactive image;
Chirality	106
Specific rotation	90
Density	83 g/cm3
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 to 104 °C (189 to 219 °F) 88
Solubility in water	89 mg/mL (20 °C)
	SMILES 76sssmmmyyy;
	InChI InChI=7779; 78; Key:8082;
	(verify)

1/single chemical
	some images
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN; US DailyMed: 32; US FDA: 31;
Pregnancy; category	AU: B3; 35;
Dependence; liability	43-1
Addiction; liability	43-2
Routes of; administration	44
ATC code	5455 (WHO) 56;
Legal status
Legal status	AU: S4 (Prescription only); CA: Schedule IV; UK: POM (Prescription only); US: Schedule III; UN: Narcotic Schedules II and III; EU: Category 2 Precursor; In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
	IUPAC name IUPAC-name;
CAS Number	5051 52;
PubChem CID	57;
PubChem SID	58;
IUPHAR/BPS	59;
DrugBank	60101;
ChemSpider	6162;
UNII	63;
KEGG	6566;
ChEBI	CHEBI:6768;
ChEMBL	ChEMBL6970;
NIAID ChemDB	71;
PDB ligand	73 (PDBe, RCSB PDB);
Chemical and physical data
Formula	CH2Ag3Al4As5Au6B7Bi8−1
Molar mass	75
3D model (JSmol)	Interactive image;
Chirality	106
Specific rotation	90
Density	83 g/cm3
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 to 104 °C (189 to 219 °F) 88
Solubility in water	89 mg/mL (20 °C)
	SMILES 76;
	InChI InChI=7779; 78; Key:8082;
	(verify)

1/single chemical
	some images
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN; US DailyMed: 32; US FDA: 31;
Pregnancy; category	AU: B3; 35;
Dependence; liability	43-1
Addiction; liability	43-2
Routes of; administration	44
ATC code	5455 (WHO) 56;
Legal status
Legal status	AU: S4 (Prescription only); CA: Schedule IV; UK: POM (Prescription only); US: Schedule III; UN: Narcotic Schedules II and III; EU: Category 2 Precursor; In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
	IUPAC name IUPAC-name;
CAS Number	5051 52;
PubChem CID	57;
PubChem SID	58;
IUPHAR/BPS	59;
DrugBank	60101;
ChemSpider	6162;
UNII	63;
KEGG	6566;
ChEBI	CHEBI:6768;
ChEMBL	ChEMBL6970;
NIAID ChemDB	71;
PDB ligand	73 (PDBe, RCSB PDB);
Chemical and physical data
Formula	CH2Ag3Al4As5Au6B7Bi8−1
Molar mass	75
3D model (JSmol)	Interactive image;
Chirality	106
Specific rotation	90
Density	83 g/cm3
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 to 104 °C (189 to 219 °F) 88
Solubility in water	89 mg/mL (20 °C)
	SMILES 76;
	InChI InChI=7779; 78; Key:8082;
	(verify)

This is the template test cases page for the sandbox of සැකිල්ල:Infobox drug. Purge this page to update the examples.
If there are many examples of a complicated template, later ones may break due to limits in MediaWiki, see the HTML comment "NewPP limit report" in the rendered page.

You can also use Special:ExpandTemplates to examine the results of template uses.

You can test how this page looks in the different skins with these links:

සැකිල්ල:Drugbox/testcases/navbox

Single chemical

Side by side comparison

mab

Side by side comparison

1/mab

some images

Cap LR

13

Clinical data

Pronunciation

/njuːˈməʊniə/

Trade names

25

Other names

72

27

EU EMA: by INN
US DailyMed: 32
US FDA: 31

Pregnancy
category

AU: B3
35

Dependence
liability

43-1

Addiction
liability

43-2

Routes of
administration

44

ATC code

5455 (WHO) 56

Legal status

AU: S4 (Prescription only) S4-cmt
CA: Schedule IV
UK: POM (Prescription only)
US: Schedule III
UN: Narcotic Schedules II and III
EU: Category 2 Precursor
In general: ℞ (Prescription only)

Pharmacokinetic data

45

46

47

47.5

Elimination half-life

48

Excretion

49

Identifiers

CAS Number

5051 52

PubChem CID

57

PubChem SID

58

IUPHAR/BPS

59

DrugBank

60101

ChemSpider

6162

UNII

63

KEGG

6566

ChEBI

CHEBI:6768

ChEMBL

ChEMBL6970

NIAID ChemDB

71

PDB ligand

73 (PDBe, RCSB PDB)

Chemical and physical data

Formula

CH₂Ag₃Al₄As₅Au₆B₇Bi₈⁻¹

Molar mass

75

3D model (JSmol)

Interactive image

106

90

83 g/cm³

84 to 85 °C (183 to 185 °F) 86

Boiling point

87 to 104 °C (189 to 219 °F) 88

Solubility in water

89 mg/mL (20 °C)

SMILES

76sssmmmyyy

InChI

InChI=7779
78
Key:8082

(verify)

vaccine

2021 expanded list

Side by side comparison

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Inactivated

Infobox drug/testcases6
Vaccine description
Vaccine type	Inactivated

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Attenuated

Infobox drug/testcases6
Vaccine description
Vaccine type	Attenuated

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Live bacteria

Infobox drug/testcases6
Vaccine description
Vaccine type	Live bacteria

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Viral vector

Infobox drug/testcases6
Vaccine description
Vaccine type	Viral vector

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Toxoid

Infobox drug/testcases6
Vaccine description
Vaccine type	Toxoid

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Subunit

Infobox drug/testcases6
Vaccine description
Vaccine type	Subunit

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Protein subunit

Infobox drug/testcases6
Vaccine description
Vaccine type	Protein subunit

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Conjugate

Infobox drug/testcases6
Vaccine description
Vaccine type	Conjugate

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Recombinant vector

Infobox drug/testcases6
Vaccine description
Vaccine type	Recombinant vector

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	DNA

Infobox drug/testcases6
Vaccine description
Vaccine type	DNA

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	RNA

Infobox drug/testcases6
Vaccine description
Vaccine type	RNA

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Heterologous

Infobox drug/testcases6
Vaccine description
Vaccine type	Heterologous

Side by side comparison

Infobox drug/testcases6
Vaccine description
Vaccine type	Vacc Type Any Text

Infobox drug/testcases6
Vaccine description
Vaccine type	Vacc Type Any Text

older tests